Open Access

Sex differences in diabetes‑induced hepatic and renal damage

  • Authors:
    • Linghuan Gao
    • Xindi Wang
    • Lei Guo
    • Wenli Zhang
    • Gengyin Wang
    • Shuying Han
    • Yuxin Zhang
  • View Affiliations

  • Published online on: February 19, 2024     https://doi.org/10.3892/etm.2024.12436
  • Article Number: 148
  • Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Diabetes mellitus (DM) is a disease that affects millions of individuals worldwide and is characterized by abnormal glucose metabolism that can induce severe damage to numerous organs throughout the body. Sex differences have been demonstrated in a number of factors associated with diabetes and its complications, such as diabetic kidney disease and diabetic liver disease. To investigate the sex differences in DM further, the changes in the weight, food and water intake, and blood sugar of mice were recorded for 8 weeks in the present study. Hematoxylin and eosin staining, Masson's trichrome staining and transmission electron microscopy were used to observe the pathological changes of liver and kidney tissues. There is no significant difference in the water intake and blood glucose concentration between db/db female and male mice was observed. However, sex differences in liver and kidney damage including glomerular injury and hepatic fibrosis were found. In conclusion, the present study characterized the features of liver and kidney damage in db/db mice and indicated that sex differences should be taken into account in experiments using female and male experimental animals. Furthermore, sex differences should be taken into account in the selection of drug interventions in experiments and in clinical drug therapy.

Introduction

Diabetes mellitus (DM) is a disorder of glucose metabolism characterized by hyperglycemia due to insufficient insulin or insulin resistance, and it is estimated to afflict 439 million individuals worldwide by 2030 due to lifestyle changes, such as extensive sitting and high fat diet (1). Chronic DM is associated with dysfunction and failure of most organs in the body such as the eyes, feet, nervous system, kidneys and liver (2).

Diabetic nephropathy (DN), a complication of diabetic microangiopathy, is a major cause of end-stage renal disease (3,4). Patients with DN have sustained proteinuria and exhibit a glomerular filtration rate in progressive decline when it is measured twice with an interval of 3-6 months, which is often associated with increased blood pressure and can eventually lead to end-stage renal disease (5,6). Liver fibrosis is another common complication that is associated with DM (7,8). It has been reported that the rate of advanced liver fibrosis is higher in individuals with diabetes compared with in those without diabetes (9). Furthermore, there is an intricate association between DM and non-alcoholic fatty liver disease (NAFLD) (10). NAFLD is characterized by a wide range of liver diseases, from benign steatosis, to inflammation, fibrosis, cirrhosis, liver failure and finally, hepatocellular carcinoma. However, this series of pathological processes is not associated with excessive alcohol, drugs or viral factors (11-14). Evidence has suggested that patients diagnosed with NAFLD have a two-fold increased risk of developing DM, particularly in those with tumors, cardiovascular disease and renal disease (15,16). Furthermore, studies have indicated that diabetes is an independent risk factor for NAFLD (17), and women with a history of gestational diabetes have an increased risk of NAFLD (18,19). Conversely, remission of hepatic steatosis may prevent the development of diabetes (20,21). From the aforementioned evidence, it was hypothesized that there may be sex differences in liver and kidney injury induced by diabetes. Therefore, db/db mice are spontaneous type 2 diabetic mice caused by Leptin receptor gene deficiency, and its pathogenesis is very similar to that of human type 2 diabetes so they were selected as a model of experimental diabetes in the present study to observe liver and kidney impairment by pathological sectioning to assess whether there are sex differences in tissue injury.

Materials and methods

Equipment and reagents

An advantage blood glucose meter and strips from Roche Diagnostics GmbH, Harris's hematoxylin and eosin (H&E) stain from Zhuhai Besso Biotechnology Co., Ltd. and a Masson staining kit (cat. no. G1340) from Beijing Solarbio Science & Technology Co., Ltd. were used in the present study. Furthermore, an optical microscope from Olympus Soft Imaging Solutions GmbH (BX53), the Hitachi H-7650 transmission electron microscope (Hitachi High-Technologies Corporation), the Leica EG1150H paraffin embedding machine (Leica Microsystems GmbH) and the Leica Leitz 1512 microtome (Leica Microsystems GmbH) were also used.

Animals

Male and female db/db (37-46 and 36-44 g, respectively) and db/m C57BLKS/J (BKS) (18-21 and 17-20 g, respectively) mice (8-9 weeks; total no., 32; n=8 for each group) were purchased from Changzhou Cavens Experimental Animal Co., Ltd. [experimental animal production license: : scxk (Su) 2016-0010] and housed in the Medical Experimental Animal Center of North China University of Science and Technology (Tangshan, China). db/db (C57BL/KSJ) mice with Leptin receptor point mutation are homozygous (-/-), db/m is heterozygous (+/-), WT is m/m mice (+/+). They were provided with Co60-irradiated chow and water, ad libitum. The animal experiments were performed in specific-pathogen-free barrier laboratory at the Experimental Animal Centre of North China University of Science and Technology (Tangshan, China). The room temperature was maintained at 23±1˚C (humidity, 55±10%) and there was a 12-h light/dark cycle. The diabetic model was defined as a blood glucose level >16.67 mmol/l. The random blood glucose concentration was periodically measured from the tail vein blood, using a scalpel to scrape through a small portion of skin at the end of the tail of each mouse. The volume of blood taken each time was 0.6 µl, and thus the damage to the experimental animal was minimal. Blood glucose testing was conducted at 0, 1, 3, 5, 6,7 weeks. The mice were starved for 8 h to carry out the oral glucose tolerance test (OGTT) at 4 weeks. Blood glucose levels were measured after glucose administration (i.g, 200 mg/kg) at time points of 0, 30, 60 and 120 min. Due to the short interval, that the tail was only scraped once before the blood samples were collected at the different time points. After feeding for 8 weeks, the mice were anaesthetized using ether, and then euthanized by cervical dislocation. Liver and kidney tissue specimens were dissected and fixed for 24 h at 4˚C in 4% neutral formaldehyde for paraffin embedding or in 2.5% glutaraldehyde for electron microscopy. The present study was approved by The Experimental Animal Ethics Committee of North China University of Science and Technology (Tangshan, China).

Histological experiments

Tissue sections of 5-µm thickness were prepared, stained with Harris's hematoxylin for 20 min, washed three times in distilled water and differentiated with 1% hydrochloric acid-alcohol for 3 sec. The sections were then washed an additional three times in distilled water, stained with eosin for 10 min, dehydrated using an ethanol gradient, clarified using xylene, sealed with neutral gum and examined using light microscopy (all performed at room temperature) (22). All steps were performed at room temperature and Image-Pro Plus 6.0 software (Media Cybernetics, Inc.) was used for analysis.

Other sections were dewaxed, fixed using Bouin's solution (Nanjing SenBeiJia Biological Technology Co., Ltd.) for 10 min and then, following the operation of a Masson staining kit, the sections were stained with Harris's hematoxylin for 5 min, washed with tap water for 2 min, differentiated with 0.5% hydrochloric acid-alcohol for 10 sec and washed with distilled water for 5 min. The sections were then stained with Masson's complex staining solution for 5 min, differentiated with 0.2% acetic acid solution for 5 min, differentiated with 5% phosphomolybdic acid solution for 5 min, rinsed 3 times with 0.2% acetic acid solution and rinsed with 2% aniline blue solution for 15 sec. Subsequently, the sections were rinsed with anhydrous ethanol for 15 sec, left for 2 h to dry, sealed with neutral gum and examined using light microscopy. All steps were performed at room temperature.

Ultrastructural observation of mouse specimens

Portions of liver and kidney tissues (1 mm³) were fixed in 2.5% glutaraldehyde for 3 h (4˚C), treated with 1% osmic acid for 1 h (4˚C), dehydrated using a 50-90% acetone gradient (4˚C) and embedded in EPON 812 (37˚C). Ultrathin sections (80 nm) were prepared after orientation under a light microscope. The sections were examined by transmission electron microscopy after dual staining with uranium acetate and lead citrate (for 15 min, respectively) at room temperature (23).

Statistical analysis

SPSS 21.0 software (IBM Corp.) was used to analyze the data. Normally distributed data are expressed as the mean ± standard deviation (n=8 for body mass, food and water intake, blood glucose and OGTT experiment, respectively; n=3 for histology of the liver and kidney tissues) and comparisons between groups were made using two-way ANOVA and Tukey's post-hoc test. P<0.05 was considered to indicate a statistically significant difference.

Results

Body mass, food and water intake, and blood glucose

The weight and food intake of the mice over 7 weeks were recorded and there were no significant differences between db/m female and male mice (P>0.05), or db/db female and male mice (P<0.05) (Tables I and II). The body mass and food intake of the db/db mice were significantly higher compared with those of the db/m mice, irrespective of sex (P<0.05; Tables I and II). In addition, there were no significant differences in water intake or blood glucose concentrations between db/m female and male mice. However, differences in water intake and blood glucose were found between db/db female and male mice malefemale P<0.05; Tables III and IV).

Table I

Results of body weight of mice in each group (n=8).

Table I

Results of body weight of mice in each group (n=8).

 Body weight (g)
Group0 weeks1 week3 weeks5 weeks6 weeks7 weeks
db/m male21.3±1.1222.8±1.0423.9±1.1325.3±1.2125.0±0.8526.3±0.76
db/m female18.6±0.8420.9±1.9123.3±0.9024.1±0.7624.6±0.9425.3±1.36
db/db male 42.0±2.48a,b 43.0±2.60a,b 46.9±1.93a,b 48.8±1.62a,b 51.4±1.44a,b 50.3±2.70a,b
db/db female 40.7±2.02a,b 43.2±2.46a,b 46.8±2.34a,b 50.2±4.58a,b 50.1±3.28a,b 49.9±3.53a,b

[i] aP<0.05 vs. db/m male and

[ii] bP<0.05 vs. db/m female. Mean ± SD.

Table II

Results of daily food intake of mice in each group (n=8).

Table II

Results of daily food intake of mice in each group (n=8).

 Daily food intake (g)
Group0 weeks1 week3 weeks5 weeks6 weeks7 weeks
db/m male3.8±0.283.2±0.123.7±0.234.0±0.213.8±0.253.9±0.18
db/m female3.5±0.253.0±0.183.4±0.183.4±0.223.5±0.243.6±0.18
db/db male 8.0±0.21a,b 7.3±0.54a,b 7.7±0.23a,b 7.3±0.32a,b 7.5±0.35a,b 7.6±0.40a,b
db/db female 7.6±0.43a,b 6.7±0.07a,b 6.6±0.34a,b 6.5±0.48a,b 6.8±0.20a,b 6.3±0.50a,b

[i] aP<0.05 vs. db/m male and

[ii] bP<0.05 vs. db/m female. Mean ± SD.

Table III

Results of daily water intake of mice in each group (n=8).

Table III

Results of daily water intake of mice in each group (n=8).

 Daily water intake (ml)
Group0 weeks1 week3 weeks5 weeks6 weeks7 weeks
db/m male4.9±0.294.6±0.304.6±0.394.9±0.304.7±0.274.7±0.32
db/m female4.0±0.273.4±0.263.8±0.323.7±0.413.6±0.313.6±0.30
db/db male 15.2±0.15a,b 14.4±1.01a,b 14.6±0.63a,b 14.9±0.21a,b 14.9±0.46a,b 14.6±0.83a,b
db/db female 10.1±0.16a,b,c 8.8±0.46a,b,c 9.3±0.18a,b,c 8.6±0.56a,b,c 9.0±0.29a,b,c 9.0±0.23a,b,c

[i] aP<0.05 vs. db/m male,

[ii] bP<0.05 vs. db/m female and

[iii] cP<0.05 vs. db/db male. Mean ± SD.

Table IV

Results of random blood glucose of mice in each group (n=8).

Table IV

Results of random blood glucose of mice in each group (n=8).

 Random blood glucose (mmol/l)
Group0 weeks1 week3 weeks5 weeks6 weeks7 weeks
db/m male6.71±0.416.43±0.536.59±0.496.31±0.417.49±0.826.23±1.18
db/m female6.49±0.456.38±0.586.30±0.686.41±0.596.08±0.465.86±0.77
db/db male 20.26±1.36a,b 21.79±1.55a,b 26.25±0.86a,b 27.14±0.57a,b 27.01±1.24a,b 26.86±2.31a,b
db/db female 18.30±0.79a,b 17.33±1.26a,b,c 17.55±1.25a,b,c 20.04±0.58a,b,c 20.68±1.30a,b,c 20.40±1.77a,b,c

[i] aP<0.05 vs. db/m male,

[ii] bP<0.05 vs. db/m female and

[iii] cP<0.05 vs. db/db male. Mean ± SD.

OGTT

OGTT was performed at the end of the 7th week. Blood glucose levels in both female and male db/m mice were significantly lower compared with those in db/db mice at 30 and 60 min (Fig. 1A). Furthermore, the area under the curve calculated for db/m mice was significantly smaller compared with that for db/db mice P<0.05; Fig. 1B). From the results of the present study, abnormal glucose tolerance in db/db mice was demonstrated; there was a notable sex difference (malefemale; P<0.05).

Histology of the liver and kidney tissues

H&E staining demonstrated that both male and female db/m mice had well-arranged liver lobules and normal structures of liver lobules, hepatic cords and sinusoids, and the hepatocytes were regular in shape, uniform in size and distributed radially around the central vein (Fig. 2). However, both male and female db/db mice had irregular hepatic lobules, disordered hepatocytes and ballooning of a number of hepatocytes, and these changes were further marked in male db/db mice (Fig. 2). Masson's trichrome staining demonstrated that there was a small amount of collagen deposition in the hepatic interstitium of male and female db/m mice. Conversely, there were numerous collagen fibers in male db/db mice but significantly less in female db/db mice (Fig. 3).

H&E staining demonstrated that the renal structure of db/m mice of both sexes was normal, whereby the glomerular outlines were clear, the glomerular basement membrane was not thickened, the mesangial matrix indicated no sign of proliferation, the tubular epithelial cells were ordered and regularly shaped, and the renal interstitium had no abnormal features. Conversely, male db/db mice had larger glomeruli (92.32 µm) and wider renal capsular space (16.11 µm) compared with db/m mice (36.33 and 5.57 µm, respectively). In female db/db mice, the glomerular volume (65.36 µm) was larger compared with db/m mice (38.46 µm) values, but the difference from the db/m mice was less marked compared with that in the male db/db mice (Fig. 4). Masson's trichrome staining demonstrated that there was a small amount of collagen deposition in the renal interstitium of db/m mice, whereas there were large numbers of collagen fibers in the renal interstitium of db/db mice. However, the renal interstitial fibrosis in the male db/db mice was significantly increased compared with that in the female db/db mice (Fig. 5). The results of the present study showed that male db/db mice had more severe liver and kidney damage compared with female db/db mice.

Electron microscopy findings in the liver and kidney tissues

Electron microscopy demonstrated that the podocyte nuclei of db/m mice were regular in shape and that the chromatin was evenly distributed. In addition, normal nucleoli, mitochondria, endoplasmic reticulum and lysosomes were observed. However, in female db/db mice, a number of the mitochondria were enlarged and collagen deposition was observed compared with db/m mice. Furthermore, in male db/db mice, the mitochondria indicated oedema and vacuolar degeneration and a large number of collagen fibers were present (Fig. 6). Transmission electron microscopy demonstrated that the glomerular basement membranes of db/m mice of both sexes were intact and indicated no thickening, and the foot processes were evenly distributed. Conversely, there was collagen deposition in the stroma of the kidneys of female db/db mice, with a larger amount of collagen present in the stroma of male db/db mice (Fig. 7). These results indicated that there are sex differences in liver and kidney ultrastructure damage in db/db mice, and male db/db mice have more severe liver and kidney ultrastructure damage compared with female db/db mice.

Discussion

To investigate whether there are sex differences in liver and kidney damage in diabetic mice, db/db mice were selected as diabetic model animals in the present study. The db/db mouse is an autosomal recessive leptin receptor gene-deficient mouse that was selected in the C57BL/KSJ strain (24). The homozygous db/db mouse spontaneously develops diabetes and shows hyperphagia and obesity from 4 weeks of age (25). Thus, the pathogenesis of its phenotype resembles that of human type 2 DM (26,27). Homozygous db/db mice are infertile, but heterozygous db/m mice can be bred by introducing the ‘misty’ gene (28). The latter has normal body mass, blood glucose and insulin concentrations, such that it can be used as a control strain in studies of db/db mice (29).

In the present study, the effects of diabetes on the liver and kidneys of db/db mice of both sexes were characterized with reference to db/m controls. As expected, the body masses and blood glucose concentrations of the db/db mice were significantly higher compared with those of the db/m mice of both sexes. However, the results of the present study demonstrated that there were sex differences in body weight and food intake of mice, but the differences were not statistically significant. This result may have been caused by the small sample size of the present study. Future studies should use an increased sample size to track sex differences in body weight. Compared with the control group, db/db mice showed hepatocyte swelling, vacuolization and collagen deposition in the liver and kidney tissues, but the degree of pathological changes in the kidney tissue was milder. In previous pathological studies conducted in humans, patients with diabetic kidney disease also showed glomerular basement membrane thickening and interstitial fibrosis (30), and those with diabetes complicated by NAFLD showed steatosis and fibrosis (31). Thus, the present findings are consistent with those in humans, which implies that the db/db mouse is a suitable model for the study of diabetes and its complications.

In the present study, there were significant differences in the body mass or blood glucose concentration of the male and female db/db mice except for week 0, and the severity of hepatic and renal fibrosis in male db/db mice was significantly higher compared with that in female db/db mice. There is controversy regarding sex differences in diabetic complications (32). However, the experimental results of the present study observed a number of sex differences in diabetic mice. The present study was a preliminary investigation, and in future studies sex differences and organ damage will be investigated more thoroughly and over a longer period of time. In addition, lipids accumulate in the liver, and the accompanying vacuolation was more pronounced in male compared with in female db/db mice. Thus, the liver and kidney fibrosis in male db/db mice also appeared to be more pronounced compared with that in female db/db mice. Consistent with this, previous studies have demonstrated that the level of proteinuria in male db/db mice is usually twice that of female mice (33), female mice demonstrate less proteinuria and vascular remodeling in their kidneys compared with male mice (34) and mice lacking estrogen receptor-α demonstrate obvious proteinuria and glomerulonephritis (35). This suggests that estrogen may limit the renal injury that is caused by diabetes. A previous clinical study has also shown that male patients with diabetes are at a higher risk of microalbuminuria and are more likely to have multiple microvascular diseases (36), which suggests that among patients with diabetes, men are more likely to develop more serious kidney disease compared with women. Engin (37) found that menopausal hormone therapy with estrogen can delay the onset of type 2 diabetes in women and can improve β-cell insulin secretion, blood glucose utilization and insulin sensitivity. Thus, the protective effect of estrogen may explain why the complications of female patients with diabetes are less severe compared with those of male patients.

A small sample size was used in the present study, and follow-up experiments should aim to determine whether estrogen is the cause of the difference in the severity of the secondary pathological changes between male and female db/db mice. However, the results of the present study suggested that the db/db mouse represents a useful model of the pathogenesis of human type 2 diabetes and secondary liver and kidney pathology. Furthermore, the lesions in the male db/db mice were significantly increased compared with those in the female mice. In future studies, physical and chemical indicators such as proteinuria should be obtained, to more specifically analyze liver and kidney injury in mice. Furthermore, the potential impact of sex should be considered when animal models are selected for the study of diabetes and other diseases, so that research can be appropriately targeted.

Acknowledgements

Not applicable.

Funding

Funding: This research was supported by grants from The Natural Science Foundation of Hebei Province (grant no. H2018209260).

Availability of data and materials

The data used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

YZ, LGa and SH designed the study. GW made substantial contributions to acquisition of data. XW and LGu performed the experiments. WZ conducted the analysis of data. YZ and SH confirm the authenticity of all the raw data. All authors read and approved the final version of the manuscript.

Ethics approval and consent to participate

The experimental protocol was approved by The Animal Experimental Ethical Inspection Form of North China University of Science and Technology (approval no. LX201935; Tangshan, China).

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Shaw JE, Sicree RA and Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 87:4–14. 2011.PubMed/NCBI View Article : Google Scholar

2 

Zheng Y, Ley SH and Hu FB: Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrino. 14:88–98. 2018.PubMed/NCBI View Article : Google Scholar

3 

Hellstrom HR: The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes-including reducing the risk of age and atherosclerosis. Med Hypotheses. 68:415–433. 2007.PubMed/NCBI View Article : Google Scholar

4 

Maggiore U, Budde K, Heemann U, Hilbrands L, Oberbauer R, Oniscu GC, Pascual J, Schwartz Sorensen S, Viklicky O and Abramowicz D: ERA-EDTA DESCARTES working group. Long-term risks of kidney living donation: Review and position paper by the ERA-EDTA DESCARTES working group. Nephrol Dial Transplant. 32:216–223. 2017.PubMed/NCBI View Article : Google Scholar

5 

Sagoo MK and Gnudi L: Diabetic nephropathy: An overview. Methods Mol Biol. 2067:3–7. 2020.PubMed/NCBI View Article : Google Scholar

6 

Sternlicht H and Bakris GL: Management of hypertension in diabetic nephropathy: How low should we go? Blood Purif. 41:139–143. 2016.PubMed/NCBI View Article : Google Scholar

7 

Chen G, Yang JC, Zhang GX, Cheng Z and Du X: Evaluation of six noninvasive methods for the detection of fibrosis in Chinese patients with obesity and nonalcoholic fatty liver disease. Obes Surg. 32:3619–3626. 2022.PubMed/NCBI View Article : Google Scholar

8 

Cigrovski Berkovic M, Virovic-Jukic L, Bilic-Curcic I and Mrzljak A: Post-transplant diabetes mellitus and preexisting liver disease-a bidirectional relationship affecting treatment and management. World J Gastroenterol. 26:2740–2757. 2020.PubMed/NCBI View Article : Google Scholar

9 

Younossi ZM: Non-alcoholic fatty liver disease-a global public health perspective. J Hepatol. 70:531–544. 2019.PubMed/NCBI View Article : Google Scholar

10 

Collins FS and Tabak LA: Policy: NIH plans to enhance reproducibility. Nature. 505:612–613. 2014.PubMed/NCBI View Article : Google Scholar

11 

Kautzky-Willer A, Abrahamian H, Weitgasser R, Fasching P, Hoppichler F and Lechleitner M: Sex- and gender-aspects in regard to clinical practice recommendations for pre-diabetes and diabetes. Wien Klin Wochenschr. 128 (Suppl 2):S151–S158. 2016.PubMed/NCBI View Article : Google Scholar : (In German).

12 

Kautzky-Willer A, Harreiter J and Pacini G: Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 37:278–316. 2016.PubMed/NCBI View Article : Google Scholar

13 

Tanase DM, Gosav EM, Costea CF, Ciocoiu M, Lacatusu CM, Maranduca MA, Ouatu A and Floria M: The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res. 2020(3920196)2020.PubMed/NCBI View Article : Google Scholar

14 

Machado MV and Diehl AM: Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology. 150:1769–1777. 2016.PubMed/NCBI View Article : Google Scholar

15 

Benedict M and Zhang X: Non-alcoholic fatty liver disease: An expanded review. World J Hepatol. 9:715–732. 2017.PubMed/NCBI View Article : Google Scholar

16 

Ioannou GN, Green P, Kerr KF and Berry K: Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification. J Hepatol. 71:523–533. 2019.PubMed/NCBI View Article : Google Scholar

17 

Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, Mishra A, Erario M and Hunt S: Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology. 62:1723–1730. 2015.PubMed/NCBI View Article : Google Scholar

18 

Hua S, Qi Q, Kizer JR, Williams-Nguyen J, Strickler HD, Thyagarajan B, Daviglus M, Talavera GA, Schneiderman N, Cotler SJ, et al: Association of liver enzymes with incident diabetes in US Hispanic/Latino adults. Diabet Med. 38(e14522)2021.PubMed/NCBI View Article : Google Scholar

19 

Fujiwara N, Qian T, Koneru B and Hoshida Y: Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases. Hepatol Res. 50:817–830. 2020.PubMed/NCBI View Article : Google Scholar

20 

American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2018. Diabetes Care. 41 (Suppl 1):S13–S27. 2018.PubMed/NCBI View Article : Google Scholar

21 

Sattari M, Bril F, Egerman R, Kalavalapalli S and Cusi K: Relationship between non-alcoholic fatty liver disease during pregnancy and abnormal glucose metabolism during and after pregnancy. J Investig Med. 68:743–747. 2020.PubMed/NCBI View Article : Google Scholar

22 

Hu ZH, Kong YY, Ren JJ, Huang TJ, Wang YQ and Liu LX: Kidney and lung tissue modifications after BDL-induced liver injury in mice are associated with increased expression of IGFBPrP1 and activation of the NF-κB inflammation pathway. Int J Clin Exp Pathol. 13:192–202. 2020.PubMed/NCBI

23 

Liu YK, Xu H, Liu F, Tao R and Yin J: Effects of serum cobalt ion concentration on the liver, kidney and heart in mice. Orthop Surg. 2:134–140. 2010.PubMed/NCBI View Article : Google Scholar

24 

Roesler WJ, Pugazhenthi S and Khandelwal RL: Hepatic glycogen metabolism in the db/db mouse. Mol Cell Biochem. 92:99–106. 1990.PubMed/NCBI View Article : Google Scholar

25 

Michurina SV, Ishchenko IY, Arkhipov SA, Cherepanova MA, Vasendin DV and Zavjalov EL: Apoptosis in the liver of male db/db mice during the development of obesity and type 2 diabetes. Vavilovskii Zhurnal Genet Selektsii. 24:435–440. 2020.PubMed/NCBI View Article : Google Scholar

26 

Zhao W, Chen L, Zhou H, Deng C, Han Q, Chen Y, Wu Q and Li S: Protective effect of carvacrol on liver injury in type 2 diabetic db/db mice. Mol Med Rep. 24(741)2021.PubMed/NCBI View Article : Google Scholar

27 

Berger C, Heyne HO, Heiland T, Dommel S, Höfling C, Guiu-Jurado E, Lorenz J, Roßner S, Dannemann M, Kelso J, et al: A novel compound heterozygous leptin receptor mutation causes more severe obesity than in Leprdb/db mice. J Lipid Res. 62(100105)2021.PubMed/NCBI View Article : Google Scholar

28 

Blokh KO, Poltorak VV, Brindak OI and Tur MI: Importance of db gene for the development of low dose streptozotocin diabetes in C57BL/KsJ mice. Probl Endokrinol (Mosk). 34:73–75. 1988.PubMed/NCBI(In Russian).

29 

Klessens CQF, Woutman TD, Veraar KAM, Zandbergen M, Valk EJ, Rotmans JI, Wolterbeek R, Bruijn JA and Bajema IM: An autopsy study suggests that diabetic nephropathy is underdiagnosed. Kidney Int. 90:149–156. 2016.PubMed/NCBI View Article : Google Scholar

30 

Lal A, Parai JL and Milroy CM: Liver pathology in first presentation diabetic ketoacidosis at autopsy. Acad Forensic Pathol. 6:271–280. 2016.PubMed/NCBI View Article : Google Scholar

31 

Ma Y, Li W, Yazdizadeh Shotorbani P, Dubansky BH, Huang L, Chaudhari S, Wu P, Wang LA, Ryou MG, Zhou Z and Ma R: Comparison of diabetic nephropathy between male and female eNOS-/-db/db mice. Am J Physiol Renal Physiol. 316:F889–F897. 2019.PubMed/NCBI View Article : Google Scholar

32 

Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, Abdelmalek MF and Suzuki A: Sex differences in nonalcoholic fatty liver disease: State of the art and identification of research gaps. Hepatology. 70:1457–1469. 2019.PubMed/NCBI View Article : Google Scholar

33 

Kang DH, Yu ES, Yoon KI and Johnson R: The impact of gender on progression of renal disease: Potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol. 164:679–688. 2004.PubMed/NCBI View Article : Google Scholar

34 

Shim GJ, Kis LL, Warner M and Gustafsson JA: Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene. Proc Natl Acad Sci USA. 101:1720–1724. 2004.PubMed/NCBI View Article : Google Scholar

35 

Singh SS, Roeters-van Lennep JE, Lemmers RFH, van Herpt TTW, Lieverse AG, Sijbrands EJG and van Hoek M: Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: A prospective cohort study. Acta Diabetol. 57:725–732. 2020.PubMed/NCBI View Article : Google Scholar

36 

Mauvais-Jarvis F, Manson JE, Stevenson JC and Fonseca VA: Menopausal hormone therapy and type 2 diabetes prevention: Evidence, mechanisms, and clinical implications. Endocr Rev. 38:173–188. 2017.PubMed/NCBI View Article : Google Scholar

37 

Engin A: Non-alcoholic fatty liver disease. Adv Exp Med Biol. 960:443–467. 2017.PubMed/NCBI View Article : Google Scholar

Related Articles

Journal Cover

April-2024
Volume 27 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gao L, Wang X, Guo L, Zhang W, Wang G, Han S and Zhang Y: Sex differences in diabetes‑induced hepatic and renal damage. Exp Ther Med 27: 148, 2024
APA
Gao, L., Wang, X., Guo, L., Zhang, W., Wang, G., Han, S., & Zhang, Y. (2024). Sex differences in diabetes‑induced hepatic and renal damage. Experimental and Therapeutic Medicine, 27, 148. https://doi.org/10.3892/etm.2024.12436
MLA
Gao, L., Wang, X., Guo, L., Zhang, W., Wang, G., Han, S., Zhang, Y."Sex differences in diabetes‑induced hepatic and renal damage". Experimental and Therapeutic Medicine 27.4 (2024): 148.
Chicago
Gao, L., Wang, X., Guo, L., Zhang, W., Wang, G., Han, S., Zhang, Y."Sex differences in diabetes‑induced hepatic and renal damage". Experimental and Therapeutic Medicine 27, no. 4 (2024): 148. https://doi.org/10.3892/etm.2024.12436